Evidence map›Paper›PMID 29201587›Full record

Article3 Biotech2018

Quinolone-resistant clinical strains of

Mouna Ben Nejma, Olfa Sioud, Maha Mastouri

Abstract read
In one paragraph

Article in 3 Biotech, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Mutations inInfection and drug resistance · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mouna Ben NejmaLaboratoire des Maladies Transmissibles et substances biologiquement actives « LR99ES27», Faculté de Pharmacie de Monastir, Avenue Avicenne, 5000 Monastir, Tunisie.
Olfa SioudLaboratoire des Maladies Transmissibles et substances biologiquement actives « LR99ES27», Faculté de Pharmacie de Monastir, Avenue Avicenne, 5000 Monastir, Tunisie.
Maha MastouriLaboratoire des Maladies Transmissibles et substances biologiquement actives « LR99ES27», Faculté de Pharmacie de Monastir, Avenue Avicenne, 5000 Monastir, Tunisie.
University of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we examined mutations in the quinolone resistance-determining regions (QRDRs) of the

Indexed as

CiprofloxacingyrAMutationsparCPseudomonas aeruginosaResistance

Identifiers

PMID29201587
PMCPMC5688038
OpenAlexW2767541545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.